(Q64139971)
Statements
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complications (English)
0 references
21 January 2018
0 references
19 May 2019
0 references
720
0 references
13 year
0 references
85 year
0 references